Christopher Brooke
Geschäftsführer bei SwanBio Therapeutics, Inc.
Vermögen: 165 734 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Christopher Brooke
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 11 | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA.
9
| Private Company | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christopher Brooke
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
Swanbio Therapeutics Ltd.
 Swanbio Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Swanbio Therapeutics Ltd. engages in the research and experimental development of biotechnology. The company was founded on September 1, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Forcefield Therapeutics Ltd. | Chairman Chief Executive Officer | ||
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Sanofi-Aventis, Inc.
 Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis, Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Scottsdale, AZ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cadena Bio, Inc.
 Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Cadena Bio, Inc. engages in the manufacture of supplements for human health and nutrition by feeding the microbiome. The company was founded in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Other | President | |
Apposite Capital LLP
 Apposite Capital LLP Investment ManagersFinance Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman | |
| BIOSURGERY S.R.L. | Corporate Officer/Principal | ||
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Armistice Capital LLC
 Armistice Capital LLC Investment ManagersFinance Armistice Capital LLC is an independent hedge fund manager and SEC-registered investment advisor headquartered in New York City. The firm was founded in 2012 by Steven Boyd. They provide discretionary investment advisory services to private investment funds and to a separately managed account client, which is also a private investment fund. | Investment Managers | Chief Executive Officer | |
SAB Capital Management
 SAB Capital Management Investment ManagersFinance Founded by Scott A. Bommer in 1998, SAB Capital Advisors LLC is a New York City-based hedge fund manager. The firm manages the SAB family of funds | Investment Managers | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VAXART, INC. | Biotechnology | Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Director/Board Member | |
| King's College London | College/University | Undergraduate Degree | |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Miscellaneous Commercial Services | Chairman | |
Massachusetts Medical Device Industry Council
 Massachusetts Medical Device Industry Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Medical Device Industry Council, also known as MassMEDIC, is the largest regional medtech association in Massachusetts. With over 300 members, the organization represents manufacturers, product developers, suppliers, research institutions, and academic health centers. | Miscellaneous Commercial Services | Director/Board Member | |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Chief Operating Officer | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 35 |
| Vereinigtes Königreich | 15 |
| Italien | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 31 |
| Finance | 6 |
| Commercial Services | 6 |
| Consumer Services | 6 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 75 |
| Corporate Officer/Principal | 36 |
| Director of Finance/CFO | 33 |
| Independent Dir/Board Member | 32 |
| Chief Executive Officer | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Alison Lawton | 24 |
| Chris Hollowood | 19 |
| David Green | 18 |
| Beth Hecht | 16 |
| David Weiner | 14 |
| Patricia Allen | 14 |
| Gerald McLaughlin | 12 |
| Vivian Liu | 12 |
| Steven Boyd | 12 |
| Richard Eisenstadt | 12 |
| Gary V. Cantrell | 12 |
| Michael E. Macaluso | 10 |
| John Tsai | 10 |
| Mark Oki | 7 |
| Karen F. Kozarsky | 6 |
- Börse
- Insiders
- Christopher Brooke
- Unternehmensverbindungen
